{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:30:14Z","timestamp":1791408614422,"version":"4.3.3"},"reference-count":186,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH062646"],"award-info":[{"award-number":["R01MH062646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH073676"],"award-info":[{"award-number":["R01MH073676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37NS031373"],"award-info":[{"award-number":["R37NS031373"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuron.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T22:01:31Z","timestamp":1493848891000},"page":"431-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":233,"title":["Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders"],"prefix":"10.1016","volume":"94","author":[{"given":"Daniel J.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Jeffrey","family":"Conn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2017.03.016_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2016.04.023","article-title":"Increased metabotropic glutamate receptor 5 signaling underlies obsessive-compulsive disorder-like behavioral and striatal circuit abnormalities in mice","volume":"80","author":"Ade","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib2","doi-asserted-by":"crossref","first-page":"12070","DOI":"10.1074\/jbc.M111.316463","article-title":"Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1\/2 kinase activation","volume":"287","author":"Ahn","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0092-8674(94)90204-6","article-title":"Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice","volume":"79","author":"Aiba","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2017.03.016_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nature07926","article-title":"Temporally precise in\u00a0vivo control of intracellular signalling","volume":"458","author":"Airan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.115.226910","article-title":"Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors","volume":"356","author":"Alt","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn992","article-title":"Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice","volume":"6","author":"Anagnostaras","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopsych.2015.12.028","article-title":"Novel dopamine therapeutics for cognitive deficits in schizophrenia","volume":"81","author":"Arnsten","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib9","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib10","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib11","doi-asserted-by":"crossref","first-page":"e32849","DOI":"10.1371\/journal.pone.0032849","article-title":"Deleterious GRM1 mutations in schizophrenia","volume":"7","author":"Ayoub","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2017.03.016_bib12","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/npp.2016.2","article-title":"An mGlu5-positive allosteric modulator rescues the neuroplasticity deficits in a genetic model of NMDA receptor hypofunction in schizophrenia","volume":"41","author":"Balu","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nn.4319","article-title":"SHANK3 controls maturation of social reward circuits in the VTA","volume":"19","author":"Bariselli","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mp.2015.113","article-title":"Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders","volume":"20","author":"Barnes","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib15","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1523\/JNEUROSCI.22-22-09679.2002","article-title":"Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes","volume":"22","author":"Benquet","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0074-7742(06)78007-2","article-title":"Cholinergic circuits and signaling in the pathophysiology of schizophrenia","volume":"78","author":"Berman","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuron.2017.03.016_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnbeh.2015.00072","article-title":"Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice","volume":"9","author":"Bhardwaj","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuron.2017.03.016_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI87526","article-title":"M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss","volume":"127","author":"Bradley","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2017.03.016_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1124\/dmd.113.052084","article-title":"Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism","volume":"41","author":"Bridges","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuron.2017.03.016_bib21","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1111\/j.1460-9568.2003.03073.x","article-title":"Disruption of prepulse inhibition in mice lacking mGluR1","volume":"18","author":"Brody","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.mp.4001404","article-title":"Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors","volume":"9","author":"Brody","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1021\/cn500128b","article-title":"Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents","volume":"5","author":"Bubser","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1460-9568.2003.02588.x","article-title":"Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in\u00a0vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity","volume":"17","author":"Bymaster","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/npp.2014.2","article-title":"Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100","volume":"39","author":"Byun","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib26","doi-asserted-by":"crossref","first-page":"18464","DOI":"10.1523\/JNEUROSCI.4719-11.2011","article-title":"Induction of activity-dependent LTD requires muscarinic receptor activation in medial prefrontal cortex","volume":"31","author":"Caruana","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2012.10.011","article-title":"Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication","volume":"697","author":"Chambon","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib29","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.0800567105","article-title":"Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia","volume":"105","author":"Chan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cell.2016.08.015","article-title":"Allosteric modulation as a unifying mechanism for receptor function and regulation","volume":"166","author":"Changeux","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2017.03.016_bib31","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/cb500560h","article-title":"Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics","volume":"9","author":"Cho","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.116.235788","article-title":"Positive allosteric modulation of the muscarinic M1 receptor improves efficacy of antipsychotics in mouse glutamatergic deficit models of behavior","volume":"359","author":"Choy","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-012-2845-3","article-title":"Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine","volume":"225","author":"Clifton","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2017.03.016_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/acsmedchemlett.5b00181","article-title":"Discovery of VU0409551\/JNJ-46778212: an mGlu5 positive allosteric modulator clinical candidate targeting schizophrenia","volume":"6","author":"Conde-Ceide","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuron.2017.03.016_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuron.2017.03.016_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrd4308","article-title":"Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders","volume":"13","author":"Conn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FBP.0b013e3282feb0ac","article-title":"Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm","volume":"19","author":"Darrah","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib39","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib40","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1021\/acs.jmedchem.6b00544","article-title":"Discovery of the potent and selective M1 PAM-agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): evaluation of efficacy and cholinergic side effects","volume":"59","author":"Davoren","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.mp.4001199","article-title":"Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"7","author":"Dean","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib42","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1523\/JNEUROSCI.0370-11.2011","article-title":"Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1\/M4 preferring muscarinic receptor agonist xanomeline","volume":"31","author":"Dencker","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-012-2751-8","article-title":"An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine","volume":"224","author":"Dencker","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2017.03.016_bib44","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1021\/jm5000563","article-title":"Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2\/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence","volume":"57","author":"Dhanya","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib45","first-page":"587","article-title":"Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs","volume":"13","author":"Digby","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.neuron.2017.03.016_bib46","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1523\/JNEUROSCI.0337-12.2012","article-title":"Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models","volume":"32","author":"Digby","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.bjp.0703574","article-title":"A\u00a0novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices","volume":"131","author":"Doherty","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature13396","article-title":"Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain","volume":"511","author":"Dor\u00e9","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib49","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib50","doi-asserted-by":"crossref","first-page":"R848","DOI":"10.1016\/S0960-9822(00)80043-3","article-title":"Synapse structure: glutamate receptors connected by the shanks","volume":"9","author":"Ehlers","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","article-title":"Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release","volume":"91","author":"Foster","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2017.03.016_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/mol.113.090563","article-title":"Discovery and characterization of a G protein-biased agonist that inhibits \u03b2-arrestin recruitment to the D2 dopamine receptor","volume":"86","author":"Free","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2017.03.016_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2016.09.021","article-title":"Ligand-dependent modulation of G protein conformation alters drug efficacy","volume":"167","author":"Furness","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2017.03.016_bib55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.105.091074","article-title":"A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2\/3 receptor agonist in mouse models predictive of antipsychotic activity","volume":"315","author":"Galici","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.106.102046","article-title":"Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice","volume":"318","author":"Galici","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"Pt A","key":"10.1016\/j.neuron.2017.03.016_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.10.005","article-title":"Deficits in the extinction of ethanol-seeking behavior following chronic intermittent ethanol exposure are attenuated with positive allosteric modulation of mGlu5","volume":"113","author":"Gass","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib58","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/npp.2015.189","article-title":"Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model","volume":"41","author":"Ghoshal","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2012.07.030","article-title":"In\u00a0vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat","volume":"64","author":"Gilmour","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib60","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/hmg\/ddw074","article-title":"mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome","volume":"25","author":"Gogliotti","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2017.03.016_bib61","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/acschemneuro.5b00123","article-title":"Role for the M1 muscarinic acetylcholine receptor in top-down cognitive processing using a touchscreen visual discrimination task in mice","volume":"6","author":"Gould","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib62","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/npp.2015.265","article-title":"Partial mGlu5 negative allosteric modulators attenuate cocaine-mediated behaviors and lack psychotomimetic-like effects","volume":"41","author":"Gould","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib63","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1021\/acschemneuro.6b00230","article-title":"Prefrontal cortex-mediated impairments in a genetic model of NMDA receptor hypofunction are reversed by the novel M1 PAM VU6004256","volume":"7","author":"Grannan","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mol.114.097220","article-title":"Molecular insights into metabotropic glutamate receptor allosteric modulation","volume":"88","author":"Gregory","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib65","article-title":"Overview of receptor allosterism","volume":"Chapter 1","author":"Gregory","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib66","doi-asserted-by":"crossref","first-page":"35320","DOI":"10.1038\/srep35320","article-title":"The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia","volume":"6","author":"Griebel","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2017.03.016_bib67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0269881108089818","article-title":"The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia","volume":"22","author":"Harrison","year":"2008","journal-title":"J.\u00a0Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neuron.2017.03.016_bib68","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1523\/JNEUROSCI.22-13-05452.2002","article-title":"Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2\/Src-family kinase pathway in cortical neurons","volume":"22","author":"Heidinger","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib69","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/cn400023y","article-title":"Is there a path forward for mGlu(2) positive allosteric modulators for the treatment of schizophrenia?","volume":"4","author":"Hopkins","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1472-8206.2012.01045.x","article-title":"Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice","volume":"27","author":"Horio","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib72","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1038\/ncomms12298","article-title":"Structure-guided development of heterodimer-selective GPCR ligands","volume":"7","author":"H\u00fcbner","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2017.03.016_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B","article-title":"Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons","volume":"27","author":"Ince","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.neuron.2017.03.016_bib74","article-title":"mGluR2\/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions","author":"Jin","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib75","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jphysparis.2013.06.002","article-title":"The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia","volume":"107","author":"Jodo","year":"2013","journal-title":"J.\u00a0Physiol. Paris"},{"key":"10.1016\/j.neuron.2017.03.016_bib76","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1523\/JNEUROSCI.1850-08.2008","article-title":"Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats","volume":"28","author":"Jones","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.114.214437","article-title":"Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders","volume":"350","author":"Kalinichev","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib78","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.112.078501","article-title":"Functional and pharmacological characteristics of\u00a0metabotropic glutamate receptors 2\/4 heterodimers","volume":"82","author":"Kammermeier","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib79","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1124\/mi.4.4.6","article-title":"Allosteric modulators: the new generation of receptor antagonist","volume":"4","author":"Kenakin","year":"2004","journal-title":"Mol. Interv."},{"key":"10.1016\/j.neuron.2017.03.016_bib81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.104.079244","article-title":"A\u00a0novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in\u00a0vivo activity and antipsychotic-like effects in rat behavioral models","volume":"313","author":"Kinney","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318218dcd5","article-title":"A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia","volume":"31","author":"Kinon","year":"2011","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib84","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib85","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nchem.2554","article-title":"Allosteric activation of membrane-bound glutamate receptors using coordination chemistry within living cells","volume":"8","author":"Kiyonaka","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2004.05.002","article-title":"Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function","volume":"103","author":"Kristiansen","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12735","article-title":"Activation and allosteric modulation of a muscarinic acetylcholine receptor","volume":"504","author":"Kruse","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib89","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","volume":"15","author":"Kurita","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nchembio.1593","article-title":"A\u00a0new mechanism of allostery in a G protein-coupled receptor dimer","volume":"10","author":"Lane","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib91","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.115.226712","article-title":"The M1 muscarinic positive allosteric modulator PQCA improves performance on translatable tests of memory and attention in rhesus monkeys","volume":"355","author":"Lange","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib92","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","article-title":"GPCR dynamics: structures in motion","volume":"117","author":"Latorraca","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuron.2017.03.016_bib94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","article-title":"Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology","volume":"28","author":"Leach","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuron.2017.03.016_bib95","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/npp.2009.194","article-title":"Molecular mechanisms of action and in\u00a0vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties","volume":"35","author":"Leach","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib96","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nn.3346","article-title":"Optical control of metabotropic glutamate receptors","volume":"16","author":"Levitz","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib97","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuron.2016.08.036","article-title":"Mechanism of assembly and cooperativity of homomeric and heteromeric metabotropic glutamate receptors","volume":"92","author":"Levitz","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2017.03.016_bib98","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.115.224071","article-title":"Discovery of D1\u00a0dopamine receptor positive allosteric modulators: characterization of pharmacology and identification of residues that regulate species selectivity","volume":"354","author":"Lewis","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib99","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2014.00087","article-title":"Sarm1\u00a0deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator","volume":"8","author":"Lin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.schres.2016.02.001","article-title":"AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study","volume":"172","author":"Litman","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuron.2017.03.016_bib101","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib102","doi-asserted-by":"crossref","first-page":"21837","DOI":"10.1074\/jbc.M604156200","article-title":"Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation","volume":"281","author":"L\u00f3pez De Jes\u00fas","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib103","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmcl.2013.05.020","article-title":"N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in rats","volume":"23","author":"Lovell","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuron.2017.03.016_bib104","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuropharm.2014.01.024","article-title":"mGluR1 within the nucleus accumbens regulates alcohol intake in mice under limited-access conditions","volume":"79","author":"Lum","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib105","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/npp.2011.145","article-title":"Fractionation of spatial memory in GRM2\/3 (mGlu2\/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition","volume":"36","author":"Lyon","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib106","doi-asserted-by":"crossref","first-page":"15950","DOI":"10.1073\/pnas.0900903106","article-title":"Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation","volume":"106","author":"Ma","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib107","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1096\/fj.06-7683com","article-title":"A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties","volume":"21","author":"Maillet","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neuron.2017.03.016_bib108","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","article-title":"Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function","volume":"21","author":"Mannaioni","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007023339544","article-title":"Direct and indirect modulation of the N-methyl D-aspartate receptor","volume":"1","author":"Marino","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuron.2017.03.016_bib110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/mol.108.052886","article-title":"Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity","volume":"75","author":"Marlo","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib111","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/mol.104.010520","article-title":"Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2","volume":"68","author":"Mathiesen","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","article-title":"Allosteric modulation of G protein-coupled receptors","volume":"47","author":"May","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuron.2017.03.016_bib113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2017.03.016_bib114","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrd.2016.28","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.113.084780","article-title":"The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization","volume":"84","author":"Milligan","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib116","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1021\/acs.jmedchem.5b00585","article-title":"Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand","volume":"58","author":"Mistry","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuron.2017.03.016_bib117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1142\/S0219635208001782","article-title":"Metaplasticity: new insights through electrophysiological investigations","volume":"7","author":"Mockett","year":"2008","journal-title":"J.\u00a0Integr. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib118","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1792-z","article-title":"Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia","volume":"174","author":"Moghaddam","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2017.03.016_bib119","doi-asserted-by":"crossref","first-page":"ra5","DOI":"10.1126\/scisignal.aab0467","article-title":"Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia","volume":"9","author":"Moreno","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuron.2017.03.016_bib120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2016.00130","article-title":"Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs","volume":"7","author":"Muguruza","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2013.09.013","article-title":"Development of allosteric modulators of GPCRs for treatment of CNS disorders","volume":"61","author":"Nickols","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2017.03.016_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.115.226597","article-title":"VU0477573: partial negative allosteric modulator of the subtype 5 metabotropic glutamate receptor with in\u00a0vivo efficacy","volume":"356","author":"Nickols","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coph.2014.12.002","article-title":"Metabotropic glutamate receptors as drug targets: what\u2019s new?","volume":"20","author":"Nicoletti","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuron.2017.03.016_bib125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.109.058768","article-title":"Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7","volume":"77","author":"Niswender","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib126","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/acschemneuro.6b00036","article-title":"Development and antiparkinsonian activity of VU0418506, a selective positive allosteric modulator of metabotropic glutamate receptor 4 homomers without activity at mGlu2\/4 heteromers","volume":"7","author":"Niswender","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib127","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1124\/mol.112.082891","article-title":"A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling","volume":"83","author":"Noetzel","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrm2299","article-title":"Heterotrimeric G protein activation by G-protein-coupled receptors","volume":"9","author":"Oldham","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature20606","article-title":"Intracellular allosteric antagonism of the CCR9 receptor","volume":"540","author":"Oswald","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/cn500003z","article-title":"M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses","volume":"5","author":"Pancani","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib131","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1073\/pnas.1512812112","article-title":"Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice","volume":"112","author":"Pancani","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib132","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuropharm.2012.12.003","article-title":"Mechanism based neurotoxicity of mGlu5 positive allosteric modulators\u2014development challenges for a promising novel antipsychotic target","volume":"82","author":"Parmentier-Batteur","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib133","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2017.03.016_bib134","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","article-title":"The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations","volume":"71","author":"Petralia","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2017.03.016_bib135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nchembio.1612","article-title":"An allosteric modulator to control endogenous G protein-coupled receptors with light","volume":"10","author":"Pittolo","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib136","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1113\/JP271153","article-title":"Are type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?","volume":"594","author":"Power","year":"2016","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuron.2017.03.016_bib137","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.03.029","article-title":"The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer\u2019s disease mouse model","volume":"287","author":"Puri","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2017.03.016_bib138","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib139","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopsych.2006.10.031","article-title":"Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia","volume":"62","author":"Reilly","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2011.08.066","article-title":"Dopamine release in the basal ganglia","volume":"198","author":"Rice","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2017.03.016_bib141","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/mol.105.016139","article-title":"A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators","volume":"68","author":"Rodriguez","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib142","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.110.067207","article-title":"Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5\u00a0reveals chemical and functional diversity and in\u00a0vivo activity in rat behavioral models of anxiolytic and antipsychotic activity","volume":"78","author":"Rodriguez","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib143","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.biopsych.2012.09.012","article-title":"Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in\u00a0vivo activity","volume":"73","author":"Rook","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib144","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuron.2015.03.063","article-title":"Biased mGlu5-positive allosteric modulators provide in\u00a0vivo efficacy without potentiating mGlu5 modulation of NMDAR currents","volume":"86","author":"Rook","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2017.03.016_bib145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/npp.2014.192","article-title":"Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder","volume":"40","author":"Rosell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib146","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.chembiol.2016.06.013","article-title":"OptoGluNAM4.1, a photoswitchable allosteric antagonist for real-time control of mGlu4 receptor activity","volume":"23","author":"Rovira","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.neuron.2017.03.016_bib147","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2017.03.016_bib148","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0269881115573403","article-title":"Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies","volume":"29","author":"Salih","year":"2015","journal-title":"J.\u00a0Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neuron.2017.03.016_bib149","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1523\/JNEUROSCI.4928-07.2008","article-title":"Metabotropic glutamate receptor type 5-dependent long-term potentiation of excitatory synapses on fast-spiking GABAergic neurons in mouse visual cortex","volume":"28","author":"Sarihi","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF03402101","article-title":"Schizophrenia: neural mechanisms for novel therapies","volume":"9","author":"Sawa","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuron.2017.03.016_bib151","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/tp.2013.3","article-title":"Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA","volume":"3","author":"Scarr","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib153","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2008.06.047","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells","volume":"55","author":"Sheffler","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib154","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib155","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.neuron.2016.05.017","article-title":"M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia","volume":"90","author":"Shen","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2017.03.016_bib156","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1073\/pnas.1508846112","article-title":"Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens","volume":"112","author":"Shin","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib157","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nchembio.2007.55","article-title":"An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission","volume":"4","author":"Shirey","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuron.2017.03.016_bib158","doi-asserted-by":"crossref","first-page":"14271","DOI":"10.1523\/JNEUROSCI.3930-09.2009","article-title":"A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning","volume":"29","author":"Shirey","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib159","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents","volume":"169","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.110.002667","article-title":"Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2017.03.016_bib161","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(00)00269-7","article-title":"Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice","volume":"397","author":"Spooren","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib162","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature18636","article-title":"Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation","volume":"535","author":"Staus","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib163","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.01.028","article-title":"Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade","volume":"639","author":"Stefani","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib164","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/npp.2014.275","article-title":"Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study","volume":"40","author":"Strube","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.24708","article-title":"Direct current stimulation induces mGluR5-dependent neocortical plasticity","volume":"80","author":"Sun","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2017.03.016_bib166","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1476-5381.2010.01184.x","article-title":"Impact of species variability and \u2018probe-dependence\u2019 on the detection and in\u00a0vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor","volume":"162","author":"Suratman","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuron.2017.03.016_bib167","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.116.236372","article-title":"An allosteric potentiator of the dopamine D1 receptor increases locomotor activity in human D1 knock-in mice without causing stereotypy or tachyphylaxis","volume":"360","author":"Svensson","year":"2017","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2017.03.016_bib168","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.1073\/pnas.0610125104","article-title":"Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function","volume":"104","author":"Tan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib169","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature17188","article-title":"Crystal structures of the M1 and M4 muscarinic acetylcholine receptors","volume":"531","author":"Thal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib170","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1523\/JNEUROSCI.1395-14.2014","article-title":"Early adolescent MK-801 exposure impairs the maturation of ventral hippocampal control of basolateral amygdala drive in the adult prefrontal cortex","volume":"34","author":"Thomases","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib171","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum","volume":"30","author":"Threlfell","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib172","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0028-3908(99)00095-7","article-title":"Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons","volume":"38","author":"Ugolini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib173","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2017.03.016_bib174","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00213-014-3813-x","article-title":"Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey","volume":"232","author":"Vardigan","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2017.03.016_bib175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc.2016.56","article-title":"Biomarker development in the precision medicine era: lung cancer as a case study","volume":"16","author":"Vargas","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuron.2017.03.016_bib176","article-title":"Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice","author":"Vicidomini","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2017.03.016_bib177","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.1416196112","article-title":"Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction","volume":"112","author":"Walker","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib178","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.conb.2009.03.011","article-title":"Protein translation in synaptic plasticity: mGluR-LTD, Fragile X","volume":"19","author":"Waung","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuron.2017.03.016_bib179","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","article-title":"Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia","volume":"87","author":"Weiner","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2017.03.016_bib180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1359-6446(01)02131-6","article-title":"Target validation of G-protein coupled receptors","volume":"7","author":"Wise","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuron.2017.03.016_bib181","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature11208","article-title":"Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function","volume":"486","author":"Won","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2017.03.016_bib182","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1017\/S1355617713000532","article-title":"Prefrontal cortex activity during response selection predicts processing speed impairment in schizophrenia","volume":"19","author":"Woodward","year":"2013","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuron.2017.03.016_bib183","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2017.03.016_bib184","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1249489","article-title":"Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator","volume":"344","author":"Wu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuron.2017.03.016_bib185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1523\/JNEUROSCI.1129-13.2014","article-title":"Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS","volume":"34","author":"Yin","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2017.03.016_bib186","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.105.090308","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes","volume":"315","author":"Zhang","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662731730199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662731730199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T21:11:19Z","timestamp":1739221879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089662731730199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":186,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S089662731730199X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2017.03.016","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}